Cheryl Scott is Director at Evolent Health, Inc. (EVH). They have made 11 open-market trades across 2 companies since 2017, most recently 2026-06-01.
CIK 0001656979
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PGNY | 19,772 | $531K |
| EVH | 73,476 | $336K |
| Total | $867K |
Shares reported on the most recent Form 4, priced at the 2026-06-03 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PGNY | SELL | 2026-06-01 | 2026-06-03 | $26.39 | $196K | +6.4% | +22.6% | +1.8% |
| PGNY | SELL | 2025-06-11 | 2025-06-12 | $22.07 | $118K | -1.6% | +10.5% | +6.5% |
| PGNY | SELL | 2024-06-28 | 2024-07-01 | $28.39 | $42K | +1.5% | -1.2% | -41.3% |
| PGNY | SELL | 2023-06-27 | 2023-07-07 | $37.27 | $44K | +8.4% | +10.5% | -10.2% |
| EVH | SELL | 2023-06-14 | 2023-06-16 | $30.01 | $142K | +7.5% | +5.8% | -8.0% |
| PGNY | SELL | 2022-11-07 | 2022-11-09 | $40.78 | $35K | -15.0% | -21.5% | -20.0% |
| EVH | SELL | 2022-08-31 | 2022-09-01 | $36.76 | $114K | +7.4% | +0.5% | -21.8% |
| PGNY | SELL | 2021-11-08 | 2021-11-10 | $66.30 | $133K | -10.2% | -25.0% | -37.5% |
| EVH | SELL | 2021-06-11 | 2021-06-15 | $19.39 | $248K | +8.5% | +12.5% | +31.3% |
| EVH | SELL | 2018-06-11 | 2018-06-12 | $22.63 | $36K | -0.2% | -0.9% | +9.3% |
| EVH | SELL | 2017-05-19 | 2017-05-23 | $23.51 | $258K | +11.6% | +10.9% | -26.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.